nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—CYP3A4—Budesonide—ulcerative colitis	0.0723	0.256	CbGbCtD
Olopatadine—CYP3A4—Methylprednisolone—ulcerative colitis	0.0323	0.115	CbGbCtD
Olopatadine—CYP3A4—Nicotine—ulcerative colitis	0.0315	0.112	CbGbCtD
Olopatadine—CYP3A4—Cholecalciferol—ulcerative colitis	0.0282	0.1	CbGbCtD
Olopatadine—CYP3A4—Triamcinolone—ulcerative colitis	0.0245	0.0868	CbGbCtD
Olopatadine—CYP3A4—Betamethasone—ulcerative colitis	0.021	0.0745	CbGbCtD
Olopatadine—CYP3A4—Prednisolone—ulcerative colitis	0.0207	0.0735	CbGbCtD
Olopatadine—CYP3A4—Hydrocortisone—ulcerative colitis	0.0196	0.0697	CbGbCtD
Olopatadine—CYP3A4—Prednisone—ulcerative colitis	0.0196	0.0694	CbGbCtD
Olopatadine—CYP3A4—Dexamethasone—ulcerative colitis	0.0122	0.0433	CbGbCtD
Olopatadine—S100A2—epithelium—ulcerative colitis	0.0122	0.113	CbGeAlD
Olopatadine—S100A13—epithelium—ulcerative colitis	0.00993	0.092	CbGeAlD
Olopatadine—S100A12—epithelium—ulcerative colitis	0.0098	0.0908	CbGeAlD
Olopatadine—S100A13—smooth muscle tissue—ulcerative colitis	0.00957	0.0886	CbGeAlD
Olopatadine—S100A2—lymphoid tissue—ulcerative colitis	0.00936	0.0867	CbGeAlD
Olopatadine—S100A1—digestive system—ulcerative colitis	0.00852	0.0789	CbGeAlD
Olopatadine—S100A13—digestive system—ulcerative colitis	0.00756	0.07	CbGeAlD
Olopatadine—S100A12—lymphoid tissue—ulcerative colitis	0.00755	0.0699	CbGeAlD
Olopatadine—S100A12—digestive system—ulcerative colitis	0.00745	0.069	CbGeAlD
Olopatadine—S100B—lymphoid tissue—ulcerative colitis	0.00745	0.069	CbGeAlD
Olopatadine—S100A13—Methyldopa—Mesalazine—ulcerative colitis	0.00604	1	CbGdCrCtD
Olopatadine—S100A13—liver—ulcerative colitis	0.00563	0.0521	CbGeAlD
Olopatadine—S100A12—liver—ulcerative colitis	0.00555	0.0514	CbGeAlD
Olopatadine—HRH1—epithelium—ulcerative colitis	0.00198	0.0184	CbGeAlD
Olopatadine—HRH1—smooth muscle tissue—ulcerative colitis	0.00191	0.0177	CbGeAlD
Olopatadine—HRH1—digestive system—ulcerative colitis	0.00151	0.014	CbGeAlD
Olopatadine—CYP3A4—digestive system—ulcerative colitis	0.00117	0.0108	CbGeAlD
Olopatadine—Imipramine—SLC22A4—ulcerative colitis	0.00116	0.226	CrCbGaD
Olopatadine—CYP3A4—liver—ulcerative colitis	0.000869	0.00805	CbGeAlD
Olopatadine—Nortriptyline—PTGS1—ulcerative colitis	0.00068	0.133	CrCbGaD
Olopatadine—Dyspnoea—Budesonide—ulcerative colitis	0.000547	0.00165	CcSEcCtD
Olopatadine—Nausea—Mercaptopurine—ulcerative colitis	0.000547	0.00165	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Triamcinolone—ulcerative colitis	0.000547	0.00165	CcSEcCtD
Olopatadine—Somnolence—Budesonide—ulcerative colitis	0.000546	0.00165	CcSEcCtD
Olopatadine—Infection—Azathioprine—ulcerative colitis	0.000545	0.00164	CcSEcCtD
Olopatadine—Weight increased—Triamcinolone—ulcerative colitis	0.000535	0.00161	CcSEcCtD
Olopatadine—Cough—Mesalazine—ulcerative colitis	0.000534	0.00161	CcSEcCtD
Olopatadine—Weight increased—Methylprednisolone—ulcerative colitis	0.000534	0.00161	CcSEcCtD
Olopatadine—Skin disorder—Azathioprine—ulcerative colitis	0.000533	0.00161	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.00053	0.0016	CcSEcCtD
Olopatadine—Nausea—Nicotine—ulcerative colitis	0.00053	0.0016	CcSEcCtD
Olopatadine—Fatigue—Budesonide—ulcerative colitis	0.000529	0.0016	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—RELA—ulcerative colitis	0.000529	0.00198	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—NFKB1—ulcerative colitis	0.000528	0.00198	CbGpPWpGaD
Olopatadine—Pain—Budesonide—ulcerative colitis	0.000525	0.00158	CcSEcCtD
Olopatadine—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000523	0.00158	CcSEcCtD
Olopatadine—Infestation—Methylprednisolone—ulcerative colitis	0.000523	0.00158	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000517	0.00156	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—JAK2—ulcerative colitis	0.000515	0.00193	CbGpPWpGaD
Olopatadine—Discomfort—Mesalazine—ulcerative colitis	0.000515	0.00155	CcSEcCtD
Olopatadine—Conjunctivitis—Triamcinolone—ulcerative colitis	0.00051	0.00154	CcSEcCtD
Olopatadine—Dry mouth—Mesalazine—ulcerative colitis	0.00051	0.00154	CcSEcCtD
Olopatadine—S100A12—Immune System—DEFA5—ulcerative colitis	0.000509	0.00191	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TNFRSF14—ulcerative colitis	0.000509	0.00191	CbGpPWpGaD
Olopatadine—Feeling abnormal—Budesonide—ulcerative colitis	0.000506	0.00153	CcSEcCtD
Olopatadine—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000502	0.00151	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—NFKB1—ulcerative colitis	0.000502	0.00188	CbGpPWpGaD
Olopatadine—Oedema—Mesalazine—ulcerative colitis	0.000499	0.00151	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—RELA—ulcerative colitis	0.000499	0.00187	CbGpPWpGaD
Olopatadine—Infection—Mesalazine—ulcerative colitis	0.000496	0.0015	CcSEcCtD
Olopatadine—Epistaxis—Triamcinolone—ulcerative colitis	0.000495	0.00149	CcSEcCtD
Olopatadine—S100A12—Immune System—ARPC2—ulcerative colitis	0.000493	0.00185	CbGpPWpGaD
Olopatadine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000493	0.00185	CbGpPWpGaD
Olopatadine—Visual impairment—Prednisolone—ulcerative colitis	0.000493	0.00149	CcSEcCtD
Olopatadine—Dry skin—Prednisone—ulcerative colitis	0.000493	0.00149	CcSEcCtD
Olopatadine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000492	0.00184	CbGpPWpGaD
Olopatadine—Nervous system disorder—Mesalazine—ulcerative colitis	0.00049	0.00148	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—JAK2—ulcerative colitis	0.000487	0.00182	CbGpPWpGaD
Olopatadine—Weight increased—Betamethasone—ulcerative colitis	0.000486	0.00146	CcSEcCtD
Olopatadine—Weight increased—Dexamethasone—ulcerative colitis	0.000486	0.00146	CcSEcCtD
Olopatadine—Body temperature increased—Budesonide—ulcerative colitis	0.000485	0.00146	CcSEcCtD
Olopatadine—Abdominal pain—Budesonide—ulcerative colitis	0.000485	0.00146	CcSEcCtD
Olopatadine—Skin disorder—Mesalazine—ulcerative colitis	0.000485	0.00146	CcSEcCtD
Olopatadine—S100B—Immune System—TNFRSF14—ulcerative colitis	0.000482	0.0018	CbGpPWpGaD
Olopatadine—S100B—Immune System—DEFA5—ulcerative colitis	0.000482	0.0018	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1R2—ulcerative colitis	0.000479	0.00179	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—NFKB1—ulcerative colitis	0.000475	0.00178	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000473	0.00143	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—CCR6—ulcerative colitis	0.000472	0.00177	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—ulcerative colitis	0.000472	0.00177	CbGpPWpGaD
Olopatadine—Rhinitis—Triamcinolone—ulcerative colitis	0.000472	0.00142	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—RELA—ulcerative colitis	0.000472	0.00177	CbGpPWpGaD
Olopatadine—Rhinitis—Methylprednisolone—ulcerative colitis	0.000471	0.00142	CcSEcCtD
Olopatadine—Pharyngitis—Triamcinolone—ulcerative colitis	0.000467	0.00141	CcSEcCtD
Olopatadine—Eye disorder—Hydrocortisone—ulcerative colitis	0.000467	0.00141	CcSEcCtD
Olopatadine—S100B—Immune System—ARPC2—ulcerative colitis	0.000467	0.00175	CbGpPWpGaD
Olopatadine—Acepromazine—ALB—ulcerative colitis	0.000467	0.0909	CrCbGaD
Olopatadine—Conjunctivitis—Dexamethasone—ulcerative colitis	0.000462	0.00139	CcSEcCtD
Olopatadine—Conjunctivitis—Betamethasone—ulcerative colitis	0.000462	0.00139	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—JAK2—ulcerative colitis	0.000458	0.00172	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1R2—ulcerative colitis	0.000453	0.0017	CbGpPWpGaD
Olopatadine—Visual impairment—Methylprednisolone—ulcerative colitis	0.000453	0.00136	CcSEcCtD
Olopatadine—Hypersensitivity—Budesonide—ulcerative colitis	0.000452	0.00136	CcSEcCtD
Olopatadine—Feeling abnormal—Azathioprine—ulcerative colitis	0.000452	0.00136	CcSEcCtD
Olopatadine—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000452	0.00136	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—FCGR2A—ulcerative colitis	0.000451	0.00169	CbGpPWpGaD
Olopatadine—Thiothixene—ALB—ulcerative colitis	0.000449	0.0874	CrCbGaD
Olopatadine—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000448	0.00135	CcSEcCtD
Olopatadine—S100B—Innate Immune System—CCR6—ulcerative colitis	0.000447	0.00167	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—ulcerative colitis	0.000446	0.00167	CbGpPWpGaD
Olopatadine—Erythema—Prednisolone—ulcerative colitis	0.000446	0.00134	CcSEcCtD
Olopatadine—Dyspnoea—Mesalazine—ulcerative colitis	0.000445	0.00134	CcSEcCtD
Olopatadine—Somnolence—Mesalazine—ulcerative colitis	0.000444	0.00134	CcSEcCtD
Olopatadine—Asthenia—Budesonide—ulcerative colitis	0.000441	0.00133	CcSEcCtD
Olopatadine—Eye disorder—Methylprednisolone—ulcerative colitis	0.000439	0.00132	CcSEcCtD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—ulcerative colitis	0.000437	0.00164	CbGpPWpGaD
Olopatadine—Erythema—Hydrocortisone—ulcerative colitis	0.000435	0.00131	CcSEcCtD
Olopatadine—Pruritus—Budesonide—ulcerative colitis	0.000434	0.00131	CcSEcCtD
Olopatadine—Body temperature increased—Azathioprine—ulcerative colitis	0.000433	0.00131	CcSEcCtD
Olopatadine—Abdominal pain—Azathioprine—ulcerative colitis	0.000433	0.00131	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000431	0.0013	CcSEcCtD
Olopatadine—Fatigue—Mesalazine—ulcerative colitis	0.000431	0.0013	CcSEcCtD
Olopatadine—Pain—Mesalazine—ulcerative colitis	0.000427	0.00129	CcSEcCtD
Olopatadine—S100B—Innate Immune System—FCGR2A—ulcerative colitis	0.000426	0.0016	CbGpPWpGaD
Olopatadine—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000424	0.00128	CcSEcCtD
Olopatadine—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000423	0.00128	CcSEcCtD
Olopatadine—Weight increased—Prednisone—ulcerative colitis	0.000423	0.00127	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—NFKB1—ulcerative colitis	0.000421	0.00157	CbGpPWpGaD
Olopatadine—Diarrhoea—Budesonide—ulcerative colitis	0.00042	0.00127	CcSEcCtD
Olopatadine—Vision blurred—Prednisolone—ulcerative colitis	0.00042	0.00127	CcSEcCtD
Olopatadine—S100A12—Immune System—CARD9—ulcerative colitis	0.000415	0.00155	CbGpPWpGaD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—ulcerative colitis	0.000414	0.00155	CbGpPWpGaD
Olopatadine—Ill-defined disorder—Prednisolone—ulcerative colitis	0.000413	0.00125	CcSEcCtD
Olopatadine—Depression—Prednisone—ulcerative colitis	0.000413	0.00125	CcSEcCtD
Olopatadine—Visual impairment—Dexamethasone—ulcerative colitis	0.000412	0.00124	CcSEcCtD
Olopatadine—Visual impairment—Betamethasone—ulcerative colitis	0.000412	0.00124	CcSEcCtD
Olopatadine—Feeling abnormal—Mesalazine—ulcerative colitis	0.000412	0.00124	CcSEcCtD
Olopatadine—Erythema—Triamcinolone—ulcerative colitis	0.00041	0.00124	CcSEcCtD
Olopatadine—Erythema—Methylprednisolone—ulcerative colitis	0.000409	0.00123	CcSEcCtD
Olopatadine—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000408	0.00123	CcSEcCtD
Olopatadine—S100A12—Immune System—IL7R—ulcerative colitis	0.000407	0.00152	CbGpPWpGaD
Olopatadine—Dizziness—Budesonide—ulcerative colitis	0.000406	0.00122	CcSEcCtD
Olopatadine—Hypersensitivity—Azathioprine—ulcerative colitis	0.000404	0.00122	CcSEcCtD
Olopatadine—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.000404	0.00122	CcSEcCtD
Olopatadine—Malaise—Prednisolone—ulcerative colitis	0.000402	0.00121	CcSEcCtD
Olopatadine—Dysgeusia—Triamcinolone—ulcerative colitis	0.000401	0.00121	CcSEcCtD
Olopatadine—Eye disorder—Betamethasone—ulcerative colitis	0.000399	0.0012	CcSEcCtD
Olopatadine—Eye disorder—Dexamethasone—ulcerative colitis	0.000399	0.0012	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—NFKB1—ulcerative colitis	0.000398	0.00149	CbGpPWpGaD
Olopatadine—Back pain—Triamcinolone—ulcerative colitis	0.000396	0.00119	CcSEcCtD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—IL6—ulcerative colitis	0.000396	0.00148	CbGpPWpGaD
Olopatadine—Abdominal pain—Mesalazine—ulcerative colitis	0.000395	0.00119	CcSEcCtD
Olopatadine—Body temperature increased—Mesalazine—ulcerative colitis	0.000395	0.00119	CcSEcCtD
Olopatadine—S100B—Immune System—CARD9—ulcerative colitis	0.000393	0.00147	CbGpPWpGaD
Olopatadine—Malaise—Hydrocortisone—ulcerative colitis	0.000392	0.00118	CcSEcCtD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—ulcerative colitis	0.000392	0.00147	CbGpPWpGaD
Olopatadine—Vomiting—Budesonide—ulcerative colitis	0.00039	0.00118	CcSEcCtD
Olopatadine—Rash—Budesonide—ulcerative colitis	0.000387	0.00117	CcSEcCtD
Olopatadine—Dermatitis—Budesonide—ulcerative colitis	0.000387	0.00117	CcSEcCtD
Olopatadine—S100B—Immune System—IL7R—ulcerative colitis	0.000385	0.00144	CbGpPWpGaD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—IL6—ulcerative colitis	0.000385	0.00144	CbGpPWpGaD
Olopatadine—Headache—Budesonide—ulcerative colitis	0.000385	0.00116	CcSEcCtD
Olopatadine—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.00038	0.00115	CcSEcCtD
Olopatadine—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000379	0.00114	CcSEcCtD
Olopatadine—Diarrhoea—Azathioprine—ulcerative colitis	0.000375	0.00113	CcSEcCtD
Olopatadine—Discomfort—Prednisolone—ulcerative colitis	0.000375	0.00113	CcSEcCtD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—IL6—ulcerative colitis	0.000374	0.0014	CbGpPWpGaD
Olopatadine—Erythema—Dexamethasone—ulcerative colitis	0.000372	0.00112	CcSEcCtD
Olopatadine—Erythema—Betamethasone—ulcerative colitis	0.000372	0.00112	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—IL6—ulcerative colitis	0.000371	0.00139	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—ulcerative colitis	0.000371	0.00139	CbGpPWpGaD
Olopatadine—Malaise—Triamcinolone—ulcerative colitis	0.000369	0.00111	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—CALM3—ulcerative colitis	0.000369	0.00138	CbGpPWpGaD
Olopatadine—Malaise—Methylprednisolone—ulcerative colitis	0.000369	0.00111	CcSEcCtD
Olopatadine—Hypersensitivity—Mesalazine—ulcerative colitis	0.000368	0.00111	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000368	0.00111	CcSEcCtD
Olopatadine—Discomfort—Hydrocortisone—ulcerative colitis	0.000366	0.0011	CcSEcCtD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—IL6—ulcerative colitis	0.000365	0.00137	CbGpPWpGaD
Olopatadine—Nausea—Budesonide—ulcerative colitis	0.000365	0.0011	CcSEcCtD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—IL6—ulcerative colitis	0.000364	0.00136	CbGpPWpGaD
Olopatadine—Oedema—Prednisolone—ulcerative colitis	0.000364	0.0011	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—RIPK2—ulcerative colitis	0.000363	0.00136	CbGpPWpGaD
Olopatadine—Dizziness—Azathioprine—ulcerative colitis	0.000363	0.00109	CcSEcCtD
Olopatadine—Asthenia—Mesalazine—ulcerative colitis	0.000358	0.00108	CcSEcCtD
Olopatadine—Cough—Triamcinolone—ulcerative colitis	0.000358	0.00108	CcSEcCtD
Olopatadine—Oedema—Hydrocortisone—ulcerative colitis	0.000355	0.00107	CcSEcCtD
Olopatadine—Clomipramine—ALB—ulcerative colitis	0.000355	0.0691	CrCbGaD
Olopatadine—Pruritus—Mesalazine—ulcerative colitis	0.000353	0.00107	CcSEcCtD
Olopatadine—Infection—Hydrocortisone—ulcerative colitis	0.000353	0.00106	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—IL6—ulcerative colitis	0.000351	0.00132	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—IL6—ulcerative colitis	0.00035	0.00131	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CALM3—ulcerative colitis	0.000349	0.00131	CbGpPWpGaD
Olopatadine—Vomiting—Azathioprine—ulcerative colitis	0.000349	0.00105	CcSEcCtD
Olopatadine—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000348	0.00105	CcSEcCtD
Olopatadine—Eye disorder—Prednisone—ulcerative colitis	0.000348	0.00105	CcSEcCtD
Olopatadine—Nortriptyline—ALB—ulcerative colitis	0.000347	0.0675	CrCbGaD
Olopatadine—Rash—Azathioprine—ulcerative colitis	0.000346	0.00104	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000346	0.00104	CcSEcCtD
Olopatadine—Dermatitis—Azathioprine—ulcerative colitis	0.000345	0.00104	CcSEcCtD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—IL6—ulcerative colitis	0.000345	0.00129	CbGpPWpGaD
Olopatadine—Skin disorder—Hydrocortisone—ulcerative colitis	0.000345	0.00104	CcSEcCtD
Olopatadine—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000345	0.00104	CcSEcCtD
Olopatadine—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000345	0.00104	CcSEcCtD
Olopatadine—Discomfort—Triamcinolone—ulcerative colitis	0.000345	0.00104	CcSEcCtD
Olopatadine—Discomfort—Methylprednisolone—ulcerative colitis	0.000344	0.00104	CcSEcCtD
Olopatadine—Headache—Azathioprine—ulcerative colitis	0.000343	0.00104	CcSEcCtD
Olopatadine—S100B—Innate Immune System—RIPK2—ulcerative colitis	0.000343	0.00129	CbGpPWpGaD
Olopatadine—Diarrhoea—Mesalazine—ulcerative colitis	0.000342	0.00103	CcSEcCtD
Olopatadine—Dry mouth—Triamcinolone—ulcerative colitis	0.000341	0.00103	CcSEcCtD
Olopatadine—Clomipramine—ABCB1—ulcerative colitis	0.000338	0.066	CrCbGaD
Olopatadine—Chlorprothixene—ABCB1—ulcerative colitis	0.000337	0.0657	CrCbGaD
Olopatadine—Immune system disorder—Prednisone—ulcerative colitis	0.000336	0.00101	CcSEcCtD
Olopatadine—Malaise—Dexamethasone—ulcerative colitis	0.000335	0.00101	CcSEcCtD
Olopatadine—Malaise—Betamethasone—ulcerative colitis	0.000335	0.00101	CcSEcCtD
Olopatadine—Oedema—Triamcinolone—ulcerative colitis	0.000334	0.00101	CcSEcCtD
Olopatadine—Infection—Triamcinolone—ulcerative colitis	0.000332	0.001	CcSEcCtD
Olopatadine—Infection—Methylprednisolone—ulcerative colitis	0.000331	0.000999	CcSEcCtD
Olopatadine—S100B—MyD88-independent cascade—IL6—ulcerative colitis	0.000331	0.00124	CbGpPWpGaD
Olopatadine—Dizziness—Mesalazine—ulcerative colitis	0.00033	0.000996	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—NOD2—ulcerative colitis	0.000329	0.00123	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CD14—ulcerative colitis	0.000327	0.00123	CbGpPWpGaD
Olopatadine—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000327	0.000986	CcSEcCtD
Olopatadine—Nausea—Azathioprine—ulcerative colitis	0.000326	0.000982	CcSEcCtD
Olopatadine—Skin disorder—Methylprednisolone—ulcerative colitis	0.000324	0.000977	CcSEcCtD
Olopatadine—Erythema—Prednisone—ulcerative colitis	0.000324	0.000976	CcSEcCtD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000323	0.00121	CbGpPWpGaD
Olopatadine—Vomiting—Mesalazine—ulcerative colitis	0.000318	0.000957	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—IL6—ulcerative colitis	0.000315	0.00118	CbGpPWpGaD
Olopatadine—Rash—Mesalazine—ulcerative colitis	0.000315	0.000949	CcSEcCtD
Olopatadine—Dermatitis—Mesalazine—ulcerative colitis	0.000315	0.000948	CcSEcCtD
Olopatadine—Headache—Mesalazine—ulcerative colitis	0.000313	0.000943	CcSEcCtD
Olopatadine—Discomfort—Betamethasone—ulcerative colitis	0.000313	0.000943	CcSEcCtD
Olopatadine—Discomfort—Dexamethasone—ulcerative colitis	0.000313	0.000943	CcSEcCtD
Olopatadine—S100B—Innate Immune System—NOD2—ulcerative colitis	0.000311	0.00117	CbGpPWpGaD
Olopatadine—Pain—Prednisolone—ulcerative colitis	0.000311	0.000937	CcSEcCtD
Olopatadine—S100B—Innate Immune System—CD14—ulcerative colitis	0.00031	0.00116	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000307	0.000924	CcSEcCtD
Olopatadine—Fatigue—Hydrocortisone—ulcerative colitis	0.000306	0.000923	CcSEcCtD
Olopatadine—Vision blurred—Prednisone—ulcerative colitis	0.000305	0.00092	CcSEcCtD
Olopatadine—Pain—Hydrocortisone—ulcerative colitis	0.000304	0.000916	CcSEcCtD
Olopatadine—Oedema—Dexamethasone—ulcerative colitis	0.000303	0.000915	CcSEcCtD
Olopatadine—Oedema—Betamethasone—ulcerative colitis	0.000303	0.000915	CcSEcCtD
Olopatadine—S100A12—Immune System—ITGAL—ulcerative colitis	0.000303	0.00113	CbGpPWpGaD
Olopatadine—Infection—Betamethasone—ulcerative colitis	0.000301	0.000909	CcSEcCtD
Olopatadine—Infection—Dexamethasone—ulcerative colitis	0.000301	0.000909	CcSEcCtD
Olopatadine—Ill-defined disorder—Prednisone—ulcerative colitis	0.0003	0.000906	CcSEcCtD
Olopatadine—Feeling abnormal—Prednisolone—ulcerative colitis	0.0003	0.000903	CcSEcCtD
Olopatadine—Dyspnoea—Triamcinolone—ulcerative colitis	0.000298	0.000899	CcSEcCtD
Olopatadine—S100B—Activated TLR4 signalling—IL6—ulcerative colitis	0.000298	0.00112	CbGpPWpGaD
Olopatadine—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000298	0.000897	CcSEcCtD
Olopatadine—Nervous system disorder—Betamethasone—ulcerative colitis	0.000298	0.000897	CcSEcCtD
Olopatadine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000297	0.00111	CbGpPWpGaD
Olopatadine—Doxepin—ABCB1—ulcerative colitis	0.000297	0.0578	CrCbGaD
Olopatadine—Nausea—Mesalazine—ulcerative colitis	0.000297	0.000894	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—IL6—ulcerative colitis	0.000296	0.00111	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—JAK2—ulcerative colitis	0.000293	0.0011	CbGpPWpGaD
Olopatadine—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000293	0.000882	CcSEcCtD
Olopatadine—Malaise—Prednisone—ulcerative colitis	0.000292	0.00088	CcSEcCtD
Olopatadine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.00029	0.000876	CcSEcCtD
Olopatadine—Fatigue—Triamcinolone—ulcerative colitis	0.000288	0.000869	CcSEcCtD
Olopatadine—S100A12—Immune System—IRF5—ulcerative colitis	0.000288	0.00108	CbGpPWpGaD
Olopatadine—Fatigue—Methylprednisolone—ulcerative colitis	0.000288	0.000867	CcSEcCtD
Olopatadine—S100B—Immune System—ITGAL—ulcerative colitis	0.000287	0.00107	CbGpPWpGaD
Olopatadine—Pain—Triamcinolone—ulcerative colitis	0.000286	0.000862	CcSEcCtD
Olopatadine—HRH1—IL-4 Signaling Pathway—RELA—ulcerative colitis	0.000284	0.00106	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000283	0.00106	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000283	0.00106	CbGpPWpGaD
Olopatadine—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000281	0.000846	CcSEcCtD
Olopatadine—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000281	0.000846	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—IL6—ulcerative colitis	0.00028	0.00105	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SEL1L—ulcerative colitis	0.000278	0.00104	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000277	0.00104	CbGpPWpGaD
Olopatadine—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000276	0.000831	CcSEcCtD
Olopatadine—S100A12—Immune System—IRF8—ulcerative colitis	0.000275	0.00103	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CCR6—ulcerative colitis	0.000275	0.00103	CbGpPWpGaD
Olopatadine—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000275	0.000829	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000274	0.000825	CcSEcCtD
Olopatadine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000273	0.000823	CcSEcCtD
Olopatadine—Discomfort—Prednisone—ulcerative colitis	0.000272	0.000821	CcSEcCtD
Olopatadine—S100B—Immune System—IRF5—ulcerative colitis	0.000272	0.00102	CbGpPWpGaD
Olopatadine—Hypersensitivity—Prednisolone—ulcerative colitis	0.000268	0.000808	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—ADCY5—ulcerative colitis	0.000268	0.001	CbGpPWpGaD
Olopatadine—Body temperature increased—Triamcinolone—ulcerative colitis	0.000264	0.000797	CcSEcCtD
Olopatadine—Oedema—Prednisone—ulcerative colitis	0.000264	0.000797	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—IL6—ulcerative colitis	0.000264	0.000988	CbGpPWpGaD
Olopatadine—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000264	0.000795	CcSEcCtD
Olopatadine—Infection—Prednisone—ulcerative colitis	0.000263	0.000791	CcSEcCtD
Olopatadine—S100A12—Immune System—FCGR2A—ulcerative colitis	0.000262	0.000983	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000262	0.00079	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000262	0.00079	CcSEcCtD
Olopatadine—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000262	0.000789	CcSEcCtD
Olopatadine—Fatigue—Betamethasone—ulcerative colitis	0.000262	0.000789	CcSEcCtD
Olopatadine—Fatigue—Dexamethasone—ulcerative colitis	0.000262	0.000789	CcSEcCtD
Olopatadine—S100B—Immune System—IRF8—ulcerative colitis	0.00026	0.000974	CbGpPWpGaD
Olopatadine—S100B—Immune System—CCR6—ulcerative colitis	0.00026	0.000974	CbGpPWpGaD
Olopatadine—Pain—Dexamethasone—ulcerative colitis	0.000259	0.000782	CcSEcCtD
Olopatadine—Pain—Betamethasone—ulcerative colitis	0.000259	0.000782	CcSEcCtD
Olopatadine—Nervous system disorder—Prednisone—ulcerative colitis	0.000259	0.000781	CcSEcCtD
Olopatadine—Skin disorder—Prednisone—ulcerative colitis	0.000257	0.000774	CcSEcCtD
Olopatadine—Asthenia—Hydrocortisone—ulcerative colitis	0.000255	0.000768	CcSEcCtD
Olopatadine—S100B—Innate Immune System—ADCY5—ulcerative colitis	0.000253	0.000947	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000253	0.000946	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PTPN2—ulcerative colitis	0.000252	0.000942	CbGpPWpGaD
Olopatadine—Pruritus—Hydrocortisone—ulcerative colitis	0.000251	0.000758	CcSEcCtD
Olopatadine—Feeling abnormal—Dexamethasone—ulcerative colitis	0.00025	0.000754	CcSEcCtD
Olopatadine—Feeling abnormal—Betamethasone—ulcerative colitis	0.00025	0.000754	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—IL6—ulcerative colitis	0.00025	0.000935	CbGpPWpGaD
Olopatadine—S100B—Immune System—FCGR2A—ulcerative colitis	0.000248	0.000929	CbGpPWpGaD
Olopatadine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000248	0.000748	CcSEcCtD
Olopatadine—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000248	0.000748	CcSEcCtD
Olopatadine—HRH1—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000248	0.000927	CbGpPWpGaD
Olopatadine—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000246	0.000743	CcSEcCtD
Olopatadine—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000246	0.000741	CcSEcCtD
Olopatadine—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000243	0.000733	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000243	0.000909	CbGpPWpGaD
Olopatadine—Amitriptyline—ALB—ulcerative colitis	0.00024	0.0469	CrCbGaD
Olopatadine—Dizziness—Prednisolone—ulcerative colitis	0.00024	0.000725	CcSEcCtD
Olopatadine—Asthenia—Triamcinolone—ulcerative colitis	0.00024	0.000723	CcSEcCtD
Olopatadine—Body temperature increased—Betamethasone—ulcerative colitis	0.00024	0.000723	CcSEcCtD
Olopatadine—Body temperature increased—Dexamethasone—ulcerative colitis	0.00024	0.000723	CcSEcCtD
Olopatadine—Abdominal pain—Dexamethasone—ulcerative colitis	0.00024	0.000723	CcSEcCtD
Olopatadine—Abdominal pain—Betamethasone—ulcerative colitis	0.00024	0.000723	CcSEcCtD
Olopatadine—Asthenia—Methylprednisolone—ulcerative colitis	0.000239	0.000722	CcSEcCtD
Olopatadine—HRH1—IL-4 Signaling Pathway—NFKB1—ulcerative colitis	0.000239	0.000896	CbGpPWpGaD
Olopatadine—S100B—Immune System—PTPN2—ulcerative colitis	0.000238	0.000891	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000238	0.000889	CbGpPWpGaD
Olopatadine—Pruritus—Triamcinolone—ulcerative colitis	0.000237	0.000713	CcSEcCtD
Olopatadine—Pruritus—Methylprednisolone—ulcerative colitis	0.000236	0.000712	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—IL6—ulcerative colitis	0.000235	0.00088	CbGpPWpGaD
Olopatadine—Dizziness—Hydrocortisone—ulcerative colitis	0.000235	0.000708	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—CRP—ulcerative colitis	0.000234	0.000876	CbGpPWpGaD
Olopatadine—Imipramine—ABCB1—ulcerative colitis	0.000231	0.045	CrCbGaD
Olopatadine—Amitriptyline—ABCB1—ulcerative colitis	0.00023	0.0447	CrCbGaD
Olopatadine—Rash—Prednisolone—ulcerative colitis	0.000229	0.000691	CcSEcCtD
Olopatadine—Dermatitis—Prednisolone—ulcerative colitis	0.000229	0.000691	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—CXCR1—ulcerative colitis	0.000229	0.000856	CbGpPWpGaD
Olopatadine—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000228	0.000688	CcSEcCtD
Olopatadine—Fatigue—Prednisone—ulcerative colitis	0.000228	0.000687	CcSEcCtD
Olopatadine—Headache—Prednisolone—ulcerative colitis	0.000228	0.000687	CcSEcCtD
Olopatadine—Vomiting—Hydrocortisone—ulcerative colitis	0.000226	0.000681	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—TLR4—ulcerative colitis	0.000224	0.00084	CbGpPWpGaD
Olopatadine—Rash—Hydrocortisone—ulcerative colitis	0.000224	0.000675	CcSEcCtD
Olopatadine—Dermatitis—Hydrocortisone—ulcerative colitis	0.000224	0.000674	CcSEcCtD
Olopatadine—Headache—Hydrocortisone—ulcerative colitis	0.000222	0.000671	CcSEcCtD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000222	0.000829	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CRP—ulcerative colitis	0.000221	0.000829	CbGpPWpGaD
Olopatadine—Dizziness—Triamcinolone—ulcerative colitis	0.000221	0.000667	CcSEcCtD
Olopatadine—Dizziness—Methylprednisolone—ulcerative colitis	0.000221	0.000665	CcSEcCtD
Olopatadine—Feeling abnormal—Prednisone—ulcerative colitis	0.000218	0.000656	CcSEcCtD
Olopatadine—Asthenia—Betamethasone—ulcerative colitis	0.000218	0.000656	CcSEcCtD
Olopatadine—Asthenia—Dexamethasone—ulcerative colitis	0.000218	0.000656	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000216	0.00081	CbGpPWpGaD
Olopatadine—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000216	0.000651	CcSEcCtD
Olopatadine—Nausea—Prednisolone—ulcerative colitis	0.000216	0.000651	CcSEcCtD
Olopatadine—HRH1—IL-4 Signaling Pathway—STAT3—ulcerative colitis	0.000215	0.000805	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CALM3—ulcerative colitis	0.000215	0.000804	CbGpPWpGaD
Olopatadine—Pruritus—Betamethasone—ulcerative colitis	0.000215	0.000647	CcSEcCtD
Olopatadine—Pruritus—Dexamethasone—ulcerative colitis	0.000215	0.000647	CcSEcCtD
Olopatadine—Vomiting—Triamcinolone—ulcerative colitis	0.000213	0.000641	CcSEcCtD
Olopatadine—S100B—Innate Immune System—TLR4—ulcerative colitis	0.000212	0.000794	CbGpPWpGaD
Olopatadine—Vomiting—Methylprednisolone—ulcerative colitis	0.000212	0.00064	CcSEcCtD
Olopatadine—S100A12—Immune System—RIPK2—ulcerative colitis	0.000212	0.000792	CbGpPWpGaD
Olopatadine—Nausea—Hydrocortisone—ulcerative colitis	0.000211	0.000636	CcSEcCtD
Olopatadine—Rash—Triamcinolone—ulcerative colitis	0.000211	0.000636	CcSEcCtD
Olopatadine—Dermatitis—Triamcinolone—ulcerative colitis	0.000211	0.000635	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—CXCR1—ulcerative colitis	0.000211	0.000789	CbGpPWpGaD
Olopatadine—Rash—Methylprednisolone—ulcerative colitis	0.00021	0.000634	CcSEcCtD
Olopatadine—Dermatitis—Methylprednisolone—ulcerative colitis	0.00021	0.000634	CcSEcCtD
Olopatadine—Headache—Triamcinolone—ulcerative colitis	0.000209	0.000632	CcSEcCtD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000209	0.000783	CbGpPWpGaD
Olopatadine—Headache—Methylprednisolone—ulcerative colitis	0.000209	0.00063	CcSEcCtD
Olopatadine—Body temperature increased—Prednisone—ulcerative colitis	0.000209	0.00063	CcSEcCtD
Olopatadine—Abdominal pain—Prednisone—ulcerative colitis	0.000209	0.00063	CcSEcCtD
Olopatadine—S100A12—Immune System—CTLA4—ulcerative colitis	0.000208	0.000781	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000208	0.00078	CbGpPWpGaD
Olopatadine—Diarrhoea—Betamethasone—ulcerative colitis	0.000208	0.000626	CcSEcCtD
Olopatadine—Diarrhoea—Dexamethasone—ulcerative colitis	0.000208	0.000626	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000203	0.000762	CbGpPWpGaD
Olopatadine—S100B—Immune System—CALM3—ulcerative colitis	0.000203	0.00076	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL20—ulcerative colitis	0.000201	0.000751	CbGpPWpGaD
Olopatadine—Dizziness—Dexamethasone—ulcerative colitis	0.000201	0.000605	CcSEcCtD
Olopatadine—Dizziness—Betamethasone—ulcerative colitis	0.000201	0.000605	CcSEcCtD
Olopatadine—S100B—Immune System—RIPK2—ulcerative colitis	0.0002	0.000749	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD79A—ulcerative colitis	0.000199	0.000745	CbGpPWpGaD
Olopatadine—Nausea—Triamcinolone—ulcerative colitis	0.000199	0.000599	CcSEcCtD
Olopatadine—Nausea—Methylprednisolone—ulcerative colitis	0.000198	0.000598	CcSEcCtD
Olopatadine—S100B—Immune System—CTLA4—ulcerative colitis	0.000197	0.000738	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000197	0.000738	CbGpPWpGaD
Olopatadine—Hypersensitivity—Prednisone—ulcerative colitis	0.000195	0.000587	CcSEcCtD
Olopatadine—Vomiting—Betamethasone—ulcerative colitis	0.000193	0.000582	CcSEcCtD
Olopatadine—Vomiting—Dexamethasone—ulcerative colitis	0.000193	0.000582	CcSEcCtD
Olopatadine—S100A12—Immune System—NOD2—ulcerative colitis	0.000192	0.000718	CbGpPWpGaD
Olopatadine—Rash—Betamethasone—ulcerative colitis	0.000191	0.000577	CcSEcCtD
Olopatadine—Rash—Dexamethasone—ulcerative colitis	0.000191	0.000577	CcSEcCtD
Olopatadine—Dermatitis—Dexamethasone—ulcerative colitis	0.000191	0.000576	CcSEcCtD
Olopatadine—Dermatitis—Betamethasone—ulcerative colitis	0.000191	0.000576	CcSEcCtD
Olopatadine—S100A12—Immune System—CD14—ulcerative colitis	0.000191	0.000714	CbGpPWpGaD
Olopatadine—Headache—Dexamethasone—ulcerative colitis	0.00019	0.000573	CcSEcCtD
Olopatadine—Headache—Betamethasone—ulcerative colitis	0.00019	0.000573	CcSEcCtD
Olopatadine—Asthenia—Prednisone—ulcerative colitis	0.00019	0.000572	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—GNA12—ulcerative colitis	0.000189	0.000707	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD79A—ulcerative colitis	0.000188	0.000704	CbGpPWpGaD
Olopatadine—Pruritus—Prednisone—ulcerative colitis	0.000187	0.000564	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—CCL20—ulcerative colitis	0.000185	0.000692	CbGpPWpGaD
Olopatadine—S100A12—Immune System—VCAM1—ulcerative colitis	0.000184	0.000689	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DQA1—ulcerative colitis	0.000184	0.000687	CbGpPWpGaD
Olopatadine—S100B—Immune System—NOD2—ulcerative colitis	0.000181	0.000679	CbGpPWpGaD
Olopatadine—Diarrhoea—Prednisone—ulcerative colitis	0.000181	0.000545	CcSEcCtD
Olopatadine—S100B—Immune System—CD14—ulcerative colitis	0.00018	0.000675	CbGpPWpGaD
Olopatadine—Nausea—Betamethasone—ulcerative colitis	0.00018	0.000543	CcSEcCtD
Olopatadine—Nausea—Dexamethasone—ulcerative colitis	0.00018	0.000543	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000179	0.000671	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCR2—ulcerative colitis	0.000179	0.00067	CbGpPWpGaD
Olopatadine—Dizziness—Prednisone—ulcerative colitis	0.000175	0.000527	CcSEcCtD
Olopatadine—S100B—Immune System—VCAM1—ulcerative colitis	0.000174	0.000652	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DQA1—ulcerative colitis	0.000174	0.00065	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCR6—ulcerative colitis	0.000168	0.00063	CbGpPWpGaD
Olopatadine—Vomiting—Prednisone—ulcerative colitis	0.000168	0.000507	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—JAK2—ulcerative colitis	0.000167	0.000624	CbGpPWpGaD
Olopatadine—Rash—Prednisone—ulcerative colitis	0.000167	0.000502	CcSEcCtD
Olopatadine—Dermatitis—Prednisone—ulcerative colitis	0.000166	0.000502	CcSEcCtD
Olopatadine—Headache—Prednisone—ulcerative colitis	0.000166	0.000499	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000165	0.000617	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000164	0.000614	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—RELA—ulcerative colitis	0.000162	0.000605	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAML2—ulcerative colitis	0.000159	0.000597	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000158	0.000593	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CD4—ulcerative colitis	0.000158	0.000592	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—JAK2—ulcerative colitis	0.000158	0.00059	CbGpPWpGaD
Olopatadine—Nausea—Prednisone—ulcerative colitis	0.000157	0.000473	CcSEcCtD
Olopatadine—S100A12—Immune System—ADCY5—ulcerative colitis	0.000156	0.000583	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCR6—ulcerative colitis	0.000155	0.00058	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—RELA—ulcerative colitis	0.000153	0.000572	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CD4—ulcerative colitis	0.00015	0.00056	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTGER4—ulcerative colitis	0.000148	0.000554	CbGpPWpGaD
Olopatadine—S100B—Immune System—ADCY5—ulcerative colitis	0.000147	0.000552	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000136	0.000511	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CRP—ulcerative colitis	0.000136	0.00051	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—NFKB1—ulcerative colitis	0.000136	0.00051	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000136	0.000508	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GHRL—ulcerative colitis	0.000136	0.000508	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CALM3—ulcerative colitis	0.000131	0.000492	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TLR4—ulcerative colitis	0.000131	0.000489	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DRB1—ulcerative colitis	0.000131	0.000489	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RIPK2—ulcerative colitis	0.000129	0.000484	CbGpPWpGaD
Olopatadine—S100B—Immune System—CRP—ulcerative colitis	0.000129	0.000483	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—NFKB1—ulcerative colitis	0.000129	0.000482	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ICAM1—ulcerative colitis	0.000125	0.000469	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—GHRL—ulcerative colitis	0.000125	0.000468	CbGpPWpGaD
Olopatadine—S100B—Immune System—TLR4—ulcerative colitis	0.000124	0.000463	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DRB1—ulcerative colitis	0.000123	0.000462	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000119	0.000446	CbGpPWpGaD
Olopatadine—S100B—Immune System—ICAM1—ulcerative colitis	0.000118	0.000444	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ADRB2—ulcerative colitis	0.000112	0.00042	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDH1—ulcerative colitis	0.000111	0.000415	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	0.000111	0.000414	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCR1—ulcerative colitis	0.000108	0.000405	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDH1—ulcerative colitis	0.000105	0.000392	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000104	0.000391	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000103	0.000387	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GNA12—ulcerative colitis	9.82e-05	0.000368	CbGpPWpGaD
Olopatadine—S100A12—Immune System—JAK2—ulcerative colitis	9.71e-05	0.000364	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	9.7e-05	0.000363	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNG—ulcerative colitis	9.53e-05	0.000357	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ADCY5—ulcerative colitis	9.53e-05	0.000357	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL20—ulcerative colitis	9.49e-05	0.000355	CbGpPWpGaD
Olopatadine—S100A12—Immune System—RELA—ulcerative colitis	9.41e-05	0.000352	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCR2—ulcerative colitis	9.31e-05	0.000349	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD4—ulcerative colitis	9.21e-05	0.000345	CbGpPWpGaD
Olopatadine—S100B—Immune System—JAK2—ulcerative colitis	9.19e-05	0.000344	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNG—ulcerative colitis	9.02e-05	0.000338	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GNA12—ulcerative colitis	8.92e-05	0.000334	CbGpPWpGaD
Olopatadine—S100B—Immune System—RELA—ulcerative colitis	8.9e-05	0.000333	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR6—ulcerative colitis	8.76e-05	0.000328	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD4—ulcerative colitis	8.71e-05	0.000326	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IL6—ulcerative colitis	8.55e-05	0.00032	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1B—ulcerative colitis	8.5e-05	0.000318	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2—ulcerative colitis	8.47e-05	0.000317	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCR2—ulcerative colitis	8.46e-05	0.000317	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—ulcerative colitis	8.09e-05	0.000303	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1B—ulcerative colitis	8.04e-05	0.000301	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2—ulcerative colitis	8.01e-05	0.0003	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR6—ulcerative colitis	7.95e-05	0.000298	CbGpPWpGaD
Olopatadine—S100A12—Immune System—NFKB1—ulcerative colitis	7.93e-05	0.000297	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SEL1L—ulcerative colitis	7.75e-05	0.00029	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PTGER4—ulcerative colitis	7.71e-05	0.000289	CbGpPWpGaD
Olopatadine—S100B—Immune System—NFKB1—ulcerative colitis	7.5e-05	0.000281	CbGpPWpGaD
Olopatadine—S100A12—Immune System—STAT3—ulcerative colitis	7.13e-05	0.000267	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GHRL—ulcerative colitis	7.06e-05	0.000264	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PTGER4—ulcerative colitis	7e-05	0.000262	CbGpPWpGaD
Olopatadine—S100B—Immune System—STAT3—ulcerative colitis	6.74e-05	0.000252	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	6.56e-05	0.000245	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GHRL—ulcerative colitis	6.41e-05	0.00024	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCR1—ulcerative colitis	6.38e-05	0.000239	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CALM3—ulcerative colitis	6.21e-05	0.000232	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—JAK2—ulcerative colitis	5.94e-05	0.000222	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADRB2—ulcerative colitis	5.84e-05	0.000219	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RELA—ulcerative colitis	5.75e-05	0.000215	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL20—ulcerative colitis	5.61e-05	0.00021	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL8—ulcerative colitis	5.42e-05	0.000203	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRB2—ulcerative colitis	5.31e-05	0.000199	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GNA12—ulcerative colitis	5.27e-05	0.000197	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2—ulcerative colitis	5.18e-05	0.000194	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCR2—ulcerative colitis	5e-05	0.000187	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL8—ulcerative colitis	4.99e-05	0.000187	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—ulcerative colitis	4.98e-05	0.000186	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	4.97e-05	0.000186	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADCY5—ulcerative colitis	4.96e-05	0.000186	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP9—ulcerative colitis	4.9e-05	0.000184	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NFKB1—ulcerative colitis	4.85e-05	0.000182	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—ulcerative colitis	4.71e-05	0.000176	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR6—ulcerative colitis	4.7e-05	0.000176	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CHP1—ulcerative colitis	4.53e-05	0.00017	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADCY5—ulcerative colitis	4.5e-05	0.000169	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAML2—ulcerative colitis	4.45e-05	0.000167	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—STAT3—ulcerative colitis	4.36e-05	0.000163	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTGER4—ulcerative colitis	4.14e-05	0.000155	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFB1—ulcerative colitis	4.04e-05	0.000151	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—DLD—ulcerative colitis	3.91e-05	0.000147	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GHRL—ulcerative colitis	3.79e-05	0.000142	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CALM3—ulcerative colitis	3.67e-05	0.000137	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RIPK2—ulcerative colitis	3.61e-05	0.000135	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TP53—ulcerative colitis	3.33e-05	0.000125	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRB2—ulcerative colitis	3.13e-05	0.000117	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—JAK2—ulcerative colitis	3.09e-05	0.000116	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—ulcerative colitis	3.04e-05	0.000114	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL8—ulcerative colitis	2.82e-05	0.000106	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—JAK2—ulcerative colitis	2.81e-05	0.000105	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2—ulcerative colitis	2.7e-05	0.000101	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADCY5—ulcerative colitis	2.66e-05	9.96e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL8—ulcerative colitis	2.56e-05	9.59e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2—ulcerative colitis	2.45e-05	9.17e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.89e-05	7.08e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.7e-05	6.38e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JAK2—ulcerative colitis	1.66e-05	6.21e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RELA—ulcerative colitis	1.61e-05	6.01e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL8—ulcerative colitis	1.51e-05	5.67e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2—ulcerative colitis	1.45e-05	5.42e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—ulcerative colitis	1.44e-05	5.39e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP9—ulcerative colitis	1.37e-05	5.13e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NFKB1—ulcerative colitis	1.35e-05	5.07e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.32e-05	4.96e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.24e-05	4.63e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STAT3—ulcerative colitis	1.22e-05	4.56e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFB1—ulcerative colitis	1.13e-05	4.22e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TP53—ulcerative colitis	9.29e-06	3.48e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARG—ulcerative colitis	9.22e-06	3.45e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—ulcerative colitis	8.5e-06	3.18e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALB—ulcerative colitis	8.29e-06	3.1e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—ulcerative colitis	7.25e-06	2.71e-05	CbGpPWpGaD
